Transferable drug resistance in enterobacteria isolated from urban infants.
Antibiotic-resistant enterobacteria, the vast majority of which carried transmissible R factors, were isolated from 81 out of a total of 100 healthy infants. There was surprisingly little correlation between previous antibacterial therapy and the resistant enterobacterial flora.
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use; D003428:Cross Infection; D004755:Enterobacteriaceae / Q000302:isolation & purification*; D004926:Escherichia coli / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D005664:Furazolidone / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D009268:Nalidixic Acid / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D010403:Penicillin Resistance; D013045:Species Specificity; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014505:Urban Population
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D009268:Nalidixic Acid; D005664:Furazolidone; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D009355:Neomycin; D013307:Streptomycin